Skip to main content

Table 3 Demographic and laboratory characteristics of the study group by glycemic control

From: Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes

  Poor glycemic control (n = 592) Good glycemic control (n = 214) P value
Age (years), median (range) 12.4 (2.8–18) 11 (2.6–17.72) 0.001*
Sex
• Male 260 98 0.64
• Female 332 116
Age of diabetes onset, median (range) 6.12 (1–14.4) 6 (1–15.1) 0.36
Diabetes duration (years), median (range) 5 (1–17) 4.8 (1–14.7) 0.01*
Insulin dose (U/kg/day), mean ± SD 1.29 ± 0.41 1.24 ± 0.32 0.1
Weight SDS, mean ± SD − 0.9 ± 1.4 − 0.69 ± 1.5 0.06
Height SDS, mean ± SD − 1.34 ± 1.2 − 1.42 ± 1.5 0.43
BMI SDS, mean ± SD − 0.6 ± 1.4 − 0.8 ± 1.3 0.06
TC (mg/dl), mean ± SD 160.42 ± 46.51 145.19 ± 40 <0.001*
TG (mg/dl), mean ± SD 85.7 ± 39.6 78.61 ± 34 0.02*
LDL (mg/dl), mean ± SD 99.5 ± 33.16 93.1 ± 28.8 0.13*
HDL (mg/dl), mean ± SD 52 ± 19.2 51.25 ± 15.25 0.6
HbA1c (%), mean ± SD 6.46 ± 1.52 6.76 ± 0.58 <0.001*
Dyslipidemia, frequency (%) 425 (71.79 %) 143 (66.82 %) 0.17
  1. *P value < 0.05 is considered significant, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein, HbA1c glycosylated hemoglobin, BMI body mass index, SDS standard deviation score